Notify me when Framework Ventures IV L.P. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| NBY | NovaBay Pharmaceuticals, Inc. | Common Stock, $0.01 par value | 45% | $74,228,505 | +$72,707,353 | 56,806,080 | +4780% | Framework Ventures IV L.P. | 16 Oct 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|